Coronary CTA for Assessing CAD - Are We There Yet?

Matthew Budoff

Cholesterol Treatment Decisions: Recent Updates to Guidelines and St…

Gary Martin

SGLT2 Inhibition in 2024: Use in Heart Failure and Mechanism of Acti…

28th Annual Heart Failure 2024: An Update on Therapy

M. Packer

The Best of AHA23 for the Primary Care Doctor

Cecilia Bahit

Should I Use a Continuous Glucose Monitor, Even if I'm Healthy?

Integrative Medicine - Astrid Pujari

A. Pujari

An Efficient Approach to Addressing Syncope in the Office

Dr. Vu Kiet Tran

V. Tran

New Generation of Stents Are Needed for Renal Vein Stenting

Transformative Endovascular Decisions Conference

M. Razavi

I Have a Carrot and a Stent, You Pick!

Koushik Reddy

The 'Familial' in Familial Hypercholesterolemia

Samuel Gidding

Peripheral Artery Disease: Simple is Hard

Michigan Medicine

R. J. Beaulieu

Physical Activity and Cardiorespiratory Fitness as Modulators of Hea…

Barry A. Franklin

Managing Iron Deficiency in Heart Failure: Recognizing the Need for …

Craig Beavers

Intravenous Iron for Heart Failure: Where Is the Evidence?

28th Annual Heart Failure 2024: An Update on Therapy

I. Pina

Controlling Blood Pressure in the Patient with HFpEF

MUSC Cardiology

J. Basile

The Cardiometabolic Syndrome: A New Framework for Understanding Hear…

San Diego Heart Failure Symposiums

P. Taub

Treating Hypertension: Goals and New Strategies for Achieving Them

San Diego Heart Failure Symposiums

J. H. Ix

Year In Review - Digoxin Can Be Effective to Control Rapid Atrial Fi…

Mary Money

Year in Review - Obesity and Cardiovascular Kidney Syndrome: New Goa…

Samina Yunus

What Every GP Should Know About Heart Failure in 2024?

Canadian Collaborative Research Network

S. Poon

ESC 2024 Insights: Major Adverse Cardiovascular Events, New Diagnose…

ESC 2024 Insights

M. Böttcher